文献速递脑血管病外科神经重症

急诊室立即全身麻醉对预防蛛网膜下腔出血后再出血的影响

Impact of immediate general anesthesia in the emergency room on prevention of rebleeding after subarachnoid hemorrhage.
PubMed 文献 · Acta Neurochir (Wien) · 2023-07-11

该研究基于长崎蛛网膜下腔出血登记研究2001至2018年3033例WFNS分级1至3级的动脉瘤性蛛网膜下腔出血患者,回顾性分析急诊室立即全身麻醉(iGA)与再出血及死亡风险的关系。多变量分析显示缺乏iGA与再出血独立相关,iGA与再出血和死亡风险降低至0.28倍相关。作者认为iGA可作为动脉瘤闭塞治疗前预防再出血的治疗方法。

要点

  • 3033例WFNS分级1至3级aSAH患者中,175例(5.8%)接受了急诊室立即全身麻醉(iGA)。
  • 多变量分析显示缺乏iGA与再出血独立相关。
  • iGA与再出血和死亡风险降低至0.28倍相关。

核心结论

  • 急诊室立即全身麻醉(iGA)管理与动脉瘤性蛛网膜下腔出血患者再出血和死亡风险降低至0.28倍相关,即使在调整患者疾病史、合并症和aSAH状态后。
  • 因此,iGA可作为动脉瘤闭塞治疗前预防再出血的治疗方法。

研究设计与样本

  • 回顾性分析长崎蛛网膜下腔出血登记研究2001至2018年3033例WFNS分级1、2或3级动脉瘤性蛛网膜下腔出血患者的临床数据。
  • iGA定义为使用静脉麻醉药和阿片类药物联合插管诱导的镇静和镇痛。
  • 使用多变量逻辑回归模型计算粗比值比和调整比值比,评估iGA与再出血/死亡风险的关联,多重插补采用全条件规范。
  • 在iGA与死亡关系的分析中,排除症状发作后3天内死亡的aSAH患者。

主要发现

  • 3033例符合纳入标准的aSAH患者中,175例(5.8%)接受了iGA(平均年龄62.4岁;49例男性)。
  • 多重插补多变量分析显示,心脏病、WFNS分级和缺乏iGA与再出血独立相关。
  • 3033例患者中,15例因症状发作后3天内死亡被排除。
  • 排除这些病例后,分析显示年龄、糖尿病、脑血管病史、WFNS分级、Fisher分级、缺乏iGA、再出血、术后再出血、无分流手术和症状性血管痉挛与死亡率独立相关。

临床怎么用

  • 作者认为iGA可作为动脉瘤闭塞治疗前预防再出血的治疗方法。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Aneurysm rebleeding is fatal in patients with aneurysmal subarachnoid hemorrhage (aSAH). We aimed to investigate whether immediate general anesthesia (iGA) management in the emergency room, upon arrival, prevents rebleeding after admission and reduces mortality following aSAH. METHODS: The clinical data of 3033 patients with World Federation of Neurosurgical Societies (WFNS) grade 1, 2, or 3 aSAH from the Nagasaki SAH Registry Study between 2001 and 2018 were retrospectively analyzed. iGA was defined as sedation and analgesia using intravenous anesthetics and opioids combined with intubation induction. We calculated crude and adjusted odds ratios to evaluate the associations between iGA and the risk of rebleeding/death using multivariable logistic regression models with fully conditional specification for multiple imputations. In the analysis of the relationship between iGA and death, we excluded patients with aSAH who died within 3 days after the onset of symptoms. RESULTS: Of the 3033 patients with aSAH who met the eligibility criteria, 175 patients (5.8%) received iGA (mean age, 62.4 years; 49 were male). Heart disease, WFNS grade, and lack of iGA were independently associated with rebleeding in the multivariable analysis with multiple imputations. Among the 3033 patients, 15 were excluded due to death within 3 days after the onset of symptoms. After excluding these cases, our analysis revealed that age, diabetes mellitus, history of cerebrovascular disease, WFNS grade, Fisher grade, lack of iGA, rebleeding, postoperative rebleeding, no shunt operation, and symptomatic spasm were independently associated with mortality. CONCLUSIONS: Management by iGA was associated with a 0.28-fold decrease in the risks of both rebleeding and mortality in patients with aSAH, even after adjusting for the patient's history of diseases, comorbidities, and aSAH status. Thus, iGA can be a treatment for the prevention of rebleeding before aneurysmal obliteration treatment.

来源:Acta Neurochir (Wien),查看原文。版权归原作者所有。

引用

  1. Yamaguchi S, Izumo T, Sato I, et al. Impact of immediate general anesthesia in the emergency room on prevention of rebleeding after subarachnoid hemorrhage. Acta Neurochir (Wien). 2023. PMID: 37434015. doi:10.1007/s00701-023-05705-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。